Mycoplasma hyorhinis VlpA-G antibody and antigen (recombinant protein)
Diagnostic anti-Mycoplasma hyorhinis VlpA-G antibodies pairs and antigen for animal health (animal Swine/Porcine/Pig infectious disease porcine enzootic pneumonia and porcine reproductive and respiratory syndrome (PRRS)) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Swine/Porcine/Pig disease testing products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-VT-P131-Tg001-Ag01 | Recombinant Mycoplasma hyorhinis VlpA-G protein | $3090.00 |
GMP-VT-P131-Tg001-Ab01 | Anti-Mycoplasma hyorhinis VlpA-G mouse monoclonal antibody (mAb) | $3090.00 |
GMP-VT-P131-Tg001-Ab02 | Anti-Mycoplasma hyorhinis VlpA-G mouse monoclonal antibody (mAb) | $3090.00 |
GMP-VT-P131-Tg001-Ab03 | Anti-Mycoplasma hyorhinis VlpA-G human monoclonal antibody (mAb) | $3090.00 |
GMP-VT-P131-Tg001-Ab04 | Anti-Mycoplasma hyorhinis VlpA-G human monoclonal antibody (mAb) | $3090.00 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. | GMP-VT-P131-Tg001-Ag01 |
Product Name | Recombinant Mycoplasma hyorhinis VlpA-G protein |
Pathogen | Mycoplasma hyorhinis |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | Anti-Mycoplasma hyorhinis VlpA-G antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Mycoplasma hyorhinis level test of animal Swine/Porcine/Pig infectious disease with porcine enzootic pneumonia and porcine reproductive and respiratory syndrome (PRRS). |
Tag | His | Product description | Recombinant Mycoplasma hyorhinis VlpA-G proteinwas expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. | GMP-VT-P131-Tg001-Ab01,GMP-VT-P131-Tg001-Ab02 |
Pathogen | Mycoplasma hyorhinis |
Product Name | Anti-Mycoplasma hyorhinis VlpA-G mouse monoclonal antibody (mAb) |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Recombinant Mycoplasma hyorhinis VlpA-G antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Mycoplasma hyorhinis antibodies in Mycoplasma hyorhinis level test of animal Swine/Porcine/Pig infectious disease with porcine enzootic pneumonia and porcine reproductive and respiratory syndrome (PRRS). |
Product description | Anti-Mycoplasma hyorhinis VlpA-G mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Mycoplasma hyorhinis antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. | GMP-VT-P131-Tg001-Ab03,GMP-VT-P131-Tg001-Ab04 |
Pathogen | Mycoplasma hyorhinis |
Product Name | Anti-Mycoplasma hyorhinis VlpA-G human monoclonal antibody (mAb) |
Expression platform | CHO |
Isotypes | Human lgG1 |
Bioactivity validation | Recombinant Mycoplasma hyorhinis VlpA-G antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Mycoplasma hyorhinis antibodies in Mycoplasma hyorhinis level test of animal Swine/Porcine/Pig infectious disease with porcine enzootic pneumonia and porcine reproductive and respiratory syndrome (PRRS). |
Product description | Anti-Mycoplasma hyorhinis VlpA-G mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Pathogen Information
Mycoplasma hyorhinis: Detailed Overview
Introduction
Mycoplasma hyorhinis, a prokaryotic bacterium, holds a prominent position within the class Mollicutes. This pathogen is intriguing due to its unique characteristics, which distinguish it from other bacteria. In this comprehensive overview, we delve into the intricacies of Mycoplasma hyorhinis, exploring its taxonomy, structural features, host range, associated diseases, and diagnostic methods.
Taxonomy and Classification
Mycoplasma hyorhinis belongs to the domain Bacteria and the class Mollicutes. Mollicutes, a class of bacteria, are characterized by their minimalistic cellular structure. What sets them apart from other bacteria is the absence of a rigid cell wall, a feature that grants them greater flexibility and adaptability. The lack of a peptidoglycan cell wall, a hallmark of most bacteria, is replaced in Mycoplasma hyorhinis by a more pliable cell membrane.
Structural Characteristics
The structural characteristics of Mycoplasma hyorhinis are both distinctive and uncomplicated. Unlike typical bacteria, Mycoplasma hyorhinis lacks a conventional cell wall, which grants it a flexible and variable cell shape. The absence of a rigid cell wall has necessitated the development of specialized adaptations for survival. Mycoplasma hyorhinis depends on the host for nutrients, making it an obligate parasitic bacterium. Key genes and proteins associated with Mycoplasma hyorhinis may involve those that play crucial roles in the composition of its cell membrane, metabolic processes, and replication mechanisms. The specific genes and proteins involved may vary among different strains, adding to the complexity of this pathogen.
Hosts and Associated Diseases
Mycoplasma hyorhinis primarily targets swine, more commonly known as pigs. In the swine industry, this pathogen is associated with a spectrum of diseases that can have significant economic and animal welfare implications. Among the diseases attributed to Mycoplasma hyorhinis infection are:
1.Enzootic Pneumonia: A respiratory disease that affects the lung tissue of infected pigs, resulting in reduced growth rates and decreased overall herd productivity.
2.Polyserositis: This condition is characterized by inflammation of the serous membranes that line the body cavities, leading to severe pleuritis and pericarditis.
3.Arthritis: Mycoplasma hyorhinis infections can cause joint inflammation and lameness in pigs, further impacting their well-being.
4.Respiratory Ailments in Swine Herds: Swine respiratory diseases associated with Mycoplasma hyorhinis can manifest as coughing, nasal discharge, and labored breathing, contributing to reduced pig health.
The prevalence of these diseases in swine populations highlights the significance of understanding and controlling Mycoplasma hyorhinis infections.
Diagnostic Methods
Accurate diagnosis of Mycoplasma hyorhinis infections is crucial for disease management and prevention. Various diagnostic methods have been developed to detect the presence of this pathogen in clinical and research settings. These methods include:
a. Polymerase Chain Reaction (PCR): PCR is a molecular technique that targets specific genes or genomic regions of Mycoplasma hyorhinis. Commonly, the 16S rRNA gene and unique protein-coding genes are amplified to enable precise detection.
b. DNA Hybridization: This method utilizes specific probes designed to identify and hybridize with the nucleic acids of Mycoplasma hyorhinis, allowing for targeted detection of the pathogen.
c. Enzyme-Linked Immunosorbent Assay (ELISA): ELISA is a serological assay that detects antibodies against Mycoplasma hyorhinis in swine. The presence of antibodies indicates previous exposure to the pathogen.
d. Culture and Isolation: Culturing Mycoplasma hyorhinis on specialized growth media is a classic approach for isolation. However, it is a time-consuming and demanding method, often reserved for specific research purposes.
e. Microscopic Examination: Electron microscopy or specialized staining techniques can be employed to visualize the morphological characteristics of Mycoplasma hyorhinis, aiding in its identification.
The choice of specific genes or proteins as diagnostic targets may vary among laboratories and strains. However, these methods collectively contribute to the accurate detection and management of Mycoplasma hyorhinis infections in swine populations.
In conclusion, Mycoplasma hyorhinis, as a member of the Mollicutes class, represents a unique and intriguing pathogen in the realm of prokaryotic bacteria. Its lack of a rigid cell wall, obligate parasitic nature, and association with swine diseases make it a subject of significant interest in the field of veterinary medicine and microbiology. Accurate diagnostic methods play a crucial role in disease management, underscoring the importance of ongoing research and understanding of this pathogen.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.